What You Should Know:

你应该知道的：

–

–

Premier

总理

, a technology-driven healthcare performance improvement company announced its

，一家技术驱动的医疗绩效改进公司宣布了其

acquisition

收购

of

的

IllumiCare

光照护理

, a healthcare technology firm renowned for its

，一家以医疗技术闻名的公司

EMR

电子病历系统

-agnostic platform. This strategic move significantly expands Premier’s capabilities in the clinical decision support (CDS) space by integrating IllumiCare’s real-time clinical and financial data at the point of care.

-agnostic平台。这一战略性举措通过在护理点整合IllumiCare的实时临床和财务数据，大幅扩展了Premier在临床决策支持（CDS）领域的能力。

– The acquisition aims to empower providers to make optimal clinical decisions while simultaneously managing costs, ultimately reducing hospital stays, easing administrative burdens, and improving patient outcomes. Financial terms of the transaction were not disclosed.

此次收购旨在帮助医疗服务提供者做出最佳临床决策，同时控制成本，最终减少住院时间、减轻行政负担并改善患者疗效。交易的财务条款尚未披露。

Enhancing Clinical Decision Support with Financial Visibility

通过财务可见性增强临床决策支持

IllumiCare, headquartered in Birmingham, AL, has built a strong reputation for enabling better clinical decisions by providing real-time data on treatment costs directly to providers. Its flagship product identifies inpatient medication and diagnostic use that is unlikely to offer clinical benefit based on established medical standards.

总部位于阿拉巴马州伯明翰的IllumiCare通过向医疗提供者直接提供治疗成本的实时数据，建立了良好的声誉，有助于更好的临床决策。其旗舰产品根据既定的医疗标准，识别出不太可能提供临床益处的住院药物和诊断使用。

Crucially, it attributes the actual supply cost to the ordering provider, making real costs transparent at the point of care. This unique approach facilitates upstream interventions in formulary and order sets and delivers highly targeted “nudges” to clinicians..

关键的是，它将实际的供应成本归因于订购供应商，使得在护理点的真实成本透明化。这种独特的方法促进了在处方集和订单套件中的上游干预，并向临床医生提供了高度针对性的“提示”。

“Hospitals are battling rising costs and shrinking margins,” said David Zito, Premier’s President of Performance Services. He added, “IllumiCare’s real-time cost attribution capabilities will be a game changer, differentiating Premier in a competitive CDS market with a smarter, more robust CDS solution.

“医院正在与不断上升的成本和缩减的利润空间作斗争，”Premier绩效服务部总裁大卫·齐托表示。他补充道：“IllumiCare的实时成本归因能力将成为一个改变游戏规则的因素，使Premier在竞争激烈的CDS市场中凭借更智能、更强大的CDS解决方案脱颖而出。”

Together, we can help create financial efficiencies for virtually any provider, in any clinical setting, while helping them deliver care that is better and safer for patients”..

“我们共同帮助几乎任何临床环境中的任何供应商创造财务效率，同时帮助他们提供对患者更好、更安全的护理。”

Impact Across the Care Continuum

贯穿护理全过程的影响

The IllumiCare platform is already utilized by over 82,000 providers, including independent physicians and ambulatory networks, and is compatible with more than 50 EMR systems across the care continuum. This broad compatibility significantly extends Premier’s existing CDS technology, allowing the combined entity to help health systems and clinically integrated networks:.

IllumiCare平台已被超过82,000名供应商使用，包括独立医生和门诊网络，并且与整个护理过程中50多个电子病历系统兼容。这种广泛的兼容性大大扩展了Premier现有的临床决策支持技术，使合并后的实体能够帮助卫生系统和临床集成网络：

Close care gaps

关闭护理缺口

Improve coding accuracy

提高编码准确性

Support outpatient risk capture

支持门诊风险捕获

Optimize clinical trial recruitment

优化临床试验招募

Succeed in value-based payment models

在基于价值的支付模式中取得成功

Post-Acquisition Plans

收购后的计划

The combined solution is expected to offer providers a more robust, turnkey solution with a demonstrated return on investment of up to 10 to one. Premier plans to begin marketing the acquired solution under its Stanson Health brand this summer. The newly combined capabilities will be officially debuted at Premier’s annual Breakthroughs Conference and Exhibition, scheduled for July 15-17 in National Harbor, MD..

该联合解决方案预计将为供应商提供一个更强大、交钥匙的解决方案，并展示出高达10比1的投资回报率。Premier计划今年夏天开始在其Stanson Health品牌下推广这一收购的解决方案。新整合的能力将在Premier年度突破性会议和展览上正式亮相，该会议定于7月15日至17日在马里兰州国家港举行。